SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #4,138CAS 3区Top JournalReview JournalHybrid

Expert Review of Neurotherapeutics

Abbreviation (ISO):EXPERT REV. NEUROTHER
Country: England•WoS SCIE Quartile: Q1•Scopus SJR: 1.106•SCImago Rank: #4,138•Identifier (ISSN):1473-7175(Print)/1744-8360(Online)•Articles / Year: 91•Estimated Publication Fee (APC): $3,358 USD
Former Names:
EXPERT REV NEUROTHER
Clarivate JCR Index Advisory: Name Changed (Active in JCR)
Clarivate IF (2026)Q1
4.3
↑ +0.9

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
67

67 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate2.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
91articles/year
7.36% Gold OA•29.85% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

2.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 3.0(IF: 4.3)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20262.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.3)
🔵 Computed
20252.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.4)
🔵 Computed
20242.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.4)
🔵 Computed
20232.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.3)
🔵 Computed
20222.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.287)
🔵 Computed
20212.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.618)
🔵 Computed
20202.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.743)
🔵 Computed
20192.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.453)
🔵 Computed
20182.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.692)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Expert Review of Neurotherapeutics (ISSN 1473-7175) provides expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer's and Parkinson's. Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points

Topics Covered (Recognized by AI)
Medicine94.4%Psychology89.5%Biology84.3%Internal medicine77.6%Psychiatry71%Neuroscience60.3%Pathology59.5%Genetics35.9%Chemistry32.5%Disease31.8%Endocrinology30.6%Biochemistry29.8%Pharmacology27.1%Surgery24.5%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,138Scopus Q1SCImago Profile
Scopus Coverage:2001-2026
Scopus Broad Areas:MedicineNeuroscience
Scopus Citation Rank (SJR)Q1
1.106

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
110

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
4.13

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,358 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations1,192
3-Year Documents299
Citable Documents260

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate37.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Neurology (clinical)Q1
Pharmacology (medical)Q1
Neuroscience (miscellaneous)Q2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区CLINICAL NEUROLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Taylor and Francis Ltd.
Publication Language
English
Frequency
Monthly
Editorial Address
EXPERT REVIEWS, UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
CLINICAL NEUROLOGY
JCRSCIE
57/296Q1
PHARMACOLOGY & PHARMACY
JCRSCIE
95/356Q2
CLINICAL NEUROLOGY
JCISCIE
164/296Q3
PHARMACOLOGY & PHARMACY
JCISCIE
157/356Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—598
20253.4115361
20243.4112789
20234.31221,440
20224.287761,129
20214.618962,113
20203.7431323,348
20193.4531123,531
20183.692873,254
2017—843,343
2016—1806,048
2015—1456,092
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Expert Review of Neurotherapeutics

WoS Q1
2356201820192020202120222023202420253.40
Annual Impact Factor Metric
2025:3.4

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 79ad9ef1-e21c-40b7-8b93-951b7a7b473a
Database Updated: 2026-10-01